Sensus Healthcare, Inc. (SRTS) Reports Q3 Loss, Tops Revenue Estimates

Core Insights - Sensus Healthcare, Inc. reported a quarterly loss of $0.06 per share, which was better than the Zacks Consensus Estimate of a loss of $0.12, representing an earnings surprise of +50.00% [1] - The company generated revenues of $6.88 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 48.36%, although this is a decline from $8.84 million in the same quarter last year [2] - Sensus Healthcare shares have decreased by approximately 46.7% year-to-date, contrasting with the S&P 500's gain of 15.6% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.09 on revenues of $6.04 million, and for the current fiscal year, it is -$0.43 on revenues of $26.34 million [7] - The estimate revisions trend for Sensus Healthcare was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Medical - Instruments industry, to which Sensus Healthcare belongs, is currently ranked in the top 35% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]